A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations

Pfeil, Alena; Mütsch, Margot; Hatz, Christoph; Szucs, Thomas D.
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p402
Academic Journal
Background: Influenza is one of the most common vaccine-preventable diseases in travellers. By performing two crosssectional questionnaire surveys during winter 2009 and winter 2010 among European travellers to resource-limited destinations, we aimed to investigate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination. Methods: Questionnaires were distributed in the waiting room to the visitors of the University of Zurich Centre for Travel' Health (CTH) in January and February 2009 and January 2010 prior to travel health counselling (CTH09 and CTH10). Questions included demographic data, travel-related characteristics and KAP regarding influenza vaccination. Data were analysed by using SPSS® version 14.0 for Windows. Differences in proportions were compared using the Chisquare test and the significance level was set at p ⩽ 0.05. Predictors for seasonal and pandemic influenza vaccination were determined by multiple logistic regression analyses. Results: With a response rate of 96.6%, 906 individuals were enrolled and 868 (92.5%) provided complete data. Seasonal influenza vaccination coverage was 13.7% (n = 119). Only 43 (14.2%) participants were vaccinated against pandemic influenza A/H1N1, mostly having received both vaccines simultaneously, the seasonal and pandemic one. Job-related purposes (44, 37%), age > 64 yrs (25, 21%) and recommendations of the family physician (27, 22.7%) were the most often reported reasons for being vaccinated. In the multiple logistic regression analyses of the pooled data increasing age (OR = 1.03, 95% CI 1.01 - 1.04), a business trip (OR = 0.39, 95% CI 0.17 - 0.92) and seasonal influenza vaccination in the previous winter seasons (OR = 12.91, 95% CI 8.09 - 20.58) were independent predictors for seasonal influenza vaccination in 2009 or 2010. Influenza vaccination recommended by the family doctor (327, 37.7%), travel to regions with known high risk of influenza (305, 35.1%), and influenza vaccination required for job purposes (233, 26.8%) were most frequently mentioned to consider influenza vaccination. Conclusions: Risk perception and vaccination coverage concerning seasonal and pandemic influenza was very poor among travellers to resource-limited destinations when compared to traditional at-risk groups. Previous access to influenza vaccination substantially facilitated vaccinations in the subsequent year. Information strategies about influenza should be intensified and include health professionals, e.g. family physicians, travel medicine practitioners and business enterprises.


Related Articles

  • Which Seasonal Flu Vaccine Is More Efficacious -- The Shot or the Nasal Spray? Gupta, Rahul // Internal Medicine Alert;11/29/2009, Vol. 31 Issue 22, p169 

    For the 2007-2008 season, the inactivated vaccine was more efficacious in preventing laboratory-confirmed symptomatic influenza A (predominately H3N2) in healthy adults than the live attenuated vaccine.

  • Influenza vaccination for travellers. J.H.; A.M.T. // CMAJ: Canadian Medical Association Journal;03/01/97, Vol. 156 Issue 5, p677 

    Discusses the importance of annual influenza vaccination for travellers. Cost-effective in the reduction of upper respiratory infections; Consideration of the varying seasons of influenza around the world; Recommendation from the US Centers for Disease Control and Prevention; Duration of...

  • TIP OF THE MONTH: People with HIV attending the Hajj.  // Pulse;9/8/2010, Vol. 70 Issue 25, p45 

    The article reports on Nigerian study suggesting that Hajj pilgrims (HPs) are likely to consult health professionals for meningococcal and influenza vaccination prior to travel.

  • Pharmacy and Travel Medicine: A Global Movement. Goodyer, Larry // Pharmacy;Jun2019, Vol. 7 Issue 2, p39 

    Highlights from the article: This is the first special edition of a journal that has focused specifically on Pharmacy Practice and travel medicine. Many will visit a pharmacy before departure for travel-related medicines and other health products, whereby a pharmacist might be approached for...

  • Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj).  // Weekly Epidemiological Record;8/9/2013, Vol. 88 Issue 32, p343 

    The article reports on the visa requirements issued by the Ministry of Health of Saudi Arabia for the health conditions of pilgrims visiting the Muslim pilgrimages Hajj and Umra in Saudi Arabia in 2013. It informs on the need for the vaccination certification for yellow fever, meningococcal...

  • Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj).  // Weekly Epidemiological Record;9/23/2011, Vol. 86 Issue 39, p425 

    The article offers information on the requirements of the Saudi Arabia Ministry of Health for entry visas for the pilgrimage to Mecca in 2011. It says that travellers from countries at risk of yellow fever should show a valid yellow fever vaccination certificate. It states that travellers and...

  • Influenza vax coverage still low in many countries.  // PharmacoEconomics & Outcomes News;5/28/2011, Issue 629, p7 

    The article discusses three studies on seasonal and pandemic influenza vaccines. One of the studies discovered that the acceptance of pediatric H1N1 influenza vaccination among minority parents of children six months to 18 years in the U.S. is low. A study that examined influenza vaccine...

  • Australian authorities are criticised for vaccine response. Sweet, Melissa // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/21/2010, Vol. 341 Issue 7769, p364 

    The article reports on a review conducted by Bryant Stokes, clinical professor of surgery at the University of Western Australia, for the state government of Western Australia, related to the adverse effects of the seasonal influenza vaccination program of the state.

  • New model shows economic benefits of aTIV versus TIV or QIV.  // PharmacoEconomics & Outcomes News;Feb2016, Vol. 745 Issue 1, p22 

    The article focuses on a study published in the journal "Infectious Diseases and Therapy" by M. Mullikin and others, in the December 4, 2015 issue, which discusses economic benefits of adjuvanted trivalent inactivated influenza vaccine (aTIV) for preventing seasonal influenza.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics